Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
Gibson CM, Pride YB, Hochberg CP, Sloan S, Sabatine MS, Cannon CP; TIMI Study Group. Gibson CM, et al. Among authors: pride yb. J Am Coll Cardiol. 2009 Dec 8;54(24):2290-5. doi: 10.1016/j.jacc.2009.09.010. J Am Coll Cardiol. 2009. PMID: 19958964 Free article. Clinical Trial.
Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days.
Pride YB, Buros JL, Lord E, Southard MC, Harrigan CJ, Ciaglo LN, Sabatine MS, Cannon CP, Gibson CM; TIMI Study Group. Pride YB, et al. J Thromb Thrombolysis. 2008 Oct;26(2):106-12. doi: 10.1007/s11239-007-0075-z. Epub 2007 Jul 12. J Thromb Thrombolysis. 2008. PMID: 17624497
Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
Gibson CM, Murphy SA, Pride YB, Kirtane AJ, Aroesty JM, Stein EB, Ciaglo LN, Southard MC, Sabatine MS, Cannon CP, Braunwald E; TIMI Study Group. Gibson CM, et al. Among authors: pride yb. Am Heart J. 2008 Jan;155(1):133-9. doi: 10.1016/j.ahj.2007.08.034. Epub 2007 Nov 19. Am Heart J. 2008. PMID: 18082504 Clinical Trial.
Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study).
Pinto DS, Kirtane AJ, Pride YB, Murphy SA, Sabatine MS, Cannon CP, Gibson CM; CLARITY-TIMI 28 Investigators. Pinto DS, et al. Among authors: pride yb. Am J Cardiol. 2008 Feb 1;101(3):303-7. doi: 10.1016/j.amjcard.2007.08.034. Epub 2007 Dec 20. Am J Cardiol. 2008. PMID: 18237589 Clinical Trial.
Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Gibson CM, Pride YB, Buros JL, Lord E, Shui A, Murphy SA, Pinto DS, Zimetbaum PJ, Sabatine MS, Cannon CP, Josephson ME; TIMI Study Group. Gibson CM, et al. Among authors: pride yb. J Am Coll Cardiol. 2008 Feb 5;51(5):546-51. doi: 10.1016/j.jacc.2007.08.061. J Am Coll Cardiol. 2008. PMID: 18237683 Free article. Clinical Trial.
Timing and duration of myocardial ischemia on Holter monitoring following percutaneous coronary intervention and their association with clinical outcomes (a PROTECT-TIMI 30 Substudy Analysis).
Gibson CM, Pride YB, Buros JL, Ciaglo LN, Morrow DA, Scirica BM, Stone PH; TIMI Study Group. Gibson CM, et al. Among authors: pride yb. Am J Cardiol. 2009 Jul 1;104(1):36-40. doi: 10.1016/j.amjcard.2009.02.044. Epub 2009 May 4. Am J Cardiol. 2009. PMID: 19576318 Clinical Trial.
Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Pride YB, Appelbaum E, Lord EE, Sloan S, Cannon CP, Sabatine MS, Gibson CM; TIMI Study Group. Pride YB, et al. Am J Cardiol. 2009 Aug 15;104(4):475-9. doi: 10.1016/j.amjcard.2009.04.005. Epub 2009 Jun 17. Am J Cardiol. 2009. PMID: 19660597 Clinical Trial.
Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
Pride YB, Wiviott SD, Buros JL, Zorkun C, Tariq MU, Antman EM, Braunwald E, Gibson CM; TIMI Study Group. Pride YB, et al. Am Heart J. 2009 Sep;158(3):e21-6. doi: 10.1016/j.ahj.2009.06.021. Am Heart J. 2009. PMID: 19699846 Clinical Trial.
45 results